Dicerna to Present at 2014 AsiaTIDES Conference

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, today announced that Bob D Brown, PhD, the Company’s Chief Scientific Officer and SVP, is scheduled to participate in the 2014 AsiaTIDES Conference more

View todays social media effects on DRNA

View the latest stocks trending across Twitter. Click to view dashboard

See who Dicerna is hiring next, click here to view